SyndicateWatch is an independent research assistant. It tracks insider buying activity reported on public SEC filings and organizes it into honest, research-backed signals. It does not promise profit, and it does not make decisions for you.
Request Free Access
Research evidence only. The combined rule remains a Research Candidate, not a production promise.
Sometimes the people who know a company best — officers, directors, and large owners — buy shares of their own company with their own money. In the United States they must report those purchases publicly, most commonly on an SEC Form 4. Think of it as a public receipt.
SyndicateWatch reads large numbers of these receipts, looks for interesting patterns such as clustered insider buying and concentrated owner purchases, and then studies what historically happened after similar patterns appeared.
We answer a practical question: If someone followed the signals with a small fixed amount, reused the money, and followed the planned exit rules, what would history say happened?
Real historical examples, not promises.
| Ticker | Company | Hold | Gain | Return |
|---|---|---|---|---|
| SMMT | Summit Therapeutics | 365d | $574.00 | +1,148% |
| LBSR | Liberty Star Uranium | 90d | $468.31 | +936% |
| MRNA | Moderna, Inc. | 365d | $417.37 | +834% |
The part many products hide. We show it because informed risk is the only honest risk.
| Ticker | Company | Hold | Loss | Return |
|---|---|---|---|---|
| PQEFF | Petroteq Energy | 365d | -$49.51 | -99.0% |
| CING | Cingulate Inc. | 365d | -$49.15 | -98.3% |
| FXLV | F45 Training | 365d | -$49.01 | -98.0% |
Hearing "some win, some lose" can sound like a casino. Research-based investing is about capital management and discipline, not luck. The app prepares you for the reality of the strategy instead of hiding it.
How much cash would you actually add from your pocket, and what would the account look like at year end? Historical reality of reusing profits and adding money only when the account runs dry.
| Year | Signals | Cash Added | Ending Value | Net ROI |
|---|---|---|---|---|
| 2024 | 42 | $850.00 | $1,340.00 | +57.6% |
| 2023 | 38 | $600.00 | $910.00 | +51.6% |
| 2022 | 45 | $1,100.00 | $1,250.00 | +13.6% |
| 2021 | 51 | $1,400.00 | $2,100.00 | +50.0% |
Historical simulations with fixed $50 positions. Real results depend on entry prices, fees, and discipline.
A signal is a research lead: a pattern that looked interesting historically. It does not mean the trade will make money.
Winning 55 times out of 100 still means losing 45 times. The system only works if users can accept losses without abandoning the plan.
A strategy can look strong historically and still hurt badly if too much money goes into one trade. Small, repeatable positions are safer than large emotional bets.
Historically, warned positions were far more likely to finish with a loss, but some recovered before the planned exit. The warning informs your risk review; it is not an automatic sell signal.
A decision-support and research tool. It helps users find insider-buying opportunities, study historical odds, and make more informed decisions.
We do not promise every signal will win. We help you find better-informed opportunities.
Enter your email and we will send you an invitation to download the Android app.